These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-004404-21 Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences not-yet-due
Completed, but no date, and reported results 2006-004296-35 An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatment bad-data
Not reported 2007-001281-33 A randomised control trial of alternative treatments to Inhibit VEGf in Age-related choroidal Neovascularisation(IVAN) 2013-12-31 due-trials
Ongoing, reported early 2008-002287-33 Effect of HMG-Co A reductase inhibition on endothelial dysfunction, bioavailability of tetrahydrobiopterin (BH4) and functional regulation of endothelial nitric oxide synthase (eNOS) in human heart fa... not-yet-due
Ongoing, reported early 2008-003293-18 Pharmacokinetics of ketamine in infants not-yet-due
Ongoing 2009-016566-82 Skin bacteria as a source of surgical infections: molecular epidemiology and prevention of wound contaimination not-yet-due
Not reported 2013-001664-34 Vit-D in CRC - A Randomised Double Blind Placebo-Controlled Clinical Trial Of a Single Oral Cholecalciferol Treatment Against Surrogate End Point Biomarkers (SEBs) In Colon Cancer (CRC) Patients 2018-04-24 due-trials